Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Public ClinicalTrials.gov record NCT00811889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52-Week, Multi-center, Double-blind, Randomized, Placebo-controlled Phase IIb Trial to Determine the Effects of Bardoxolone Methyl (RTA 402) on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease With an eGFR of 20 - 45 mL/Min/1.73m2
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assesses the effects of bardoxolone methyl (RTA 402) in patients with type 2 diabetes and chronic kidney disease.
Study identification
- NCT ID
- NCT00811889
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 227 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2009 (Actual)
- Primary completion
- May 31, 2010 (Actual)
- Completion
- Dec 31, 2010 (Actual)
- Last update posted
- May 29, 2025
2009 – 2010
United States locations
- U.S. sites
- 42
- U.S. states
- 21
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Montgomery | Alabama | 36106 | — |
| Not listed | Chula Vista | California | 91910 | — |
| Not listed | La Mesa | California | 91942 | — |
| Not listed | Mission Viejo | California | 92691 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Riverside | California | 92505 | — |
| Not listed | San Dimas | California | 91773 | — |
| Not listed | Middlebury | Connecticut | 06762 | — |
| Not listed | Washington D.C. | District of Columbia | 20036 | — |
| Not listed | Brandon | Florida | 33511 | — |
| Not listed | Miami | Florida | 33173 | — |
| Not listed | Pembroke Pines | Florida | 33028 | — |
| Not listed | Port Charlotte | Florida | 33952 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Chicago | Illinois | 60616 | — |
| Not listed | Peoria | Illinois | 61603 | — |
| Not listed | Baton Rouge | Louisiana | 70809 | — |
| Not listed | Portland | Maine | 04102 | — |
| Not listed | Baltimore | Maryland | 21237 | — |
| Not listed | Flint | Michigan | 48504 | — |
| Not listed | Brooklyn Center | Minnesota | 55430 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | Springfield Gardens | New York | 11413 | — |
| Not listed | Morehead City | North Carolina | 28557 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Roseburg | Oregon | 97471 | — |
| Not listed | Allentown | Pennsylvania | 18103 | — |
| Not listed | Pittsburgh | Pennsylvania | 15224 | — |
| Not listed | Pittsburgh | Pennsylvania | 15240 | — |
| Not listed | Providence | Rhode Island | 02904 | — |
| Not listed | Nashville | Tennessee | 37205 | — |
| Not listed | Corpus Christi | Texas | 78404 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | El Paso | Texas | 79935 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | San Antonio | Texas | 78205 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salem | Virginia | 24153 | — |
| Not listed | Federal Way | Washington | 98003 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00811889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 29, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00811889 live on ClinicalTrials.gov.